Insider · CIK 0001388853

DOTSON JERROLD DUANE

Reports to the SEC for 2 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001388853

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-06-30	VTGNVistagen Therapeutics, Inc.A Award	VP, CFO	AAward	+167 sh	$1.59	+$265.446	3,671
2022-12-30	VTGNVistagen Therapeutics, Inc.A Award	VP, CFO	AAward	+5,000 sh	$0.09	+$438	105,111
2022-07-30	VTGNVistagen Therapeutics, Inc.A Award	VP, CFO	AAward	+5,000 sh	$0.75	+$3,740	100,111
2022-03-01	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	VP, CFO	AAward	+150K sh	—	—	150,000
2022-01-11	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	VP, CFO	MExercise/Conversion	−18.8K sh	—	—	15,625
2022-01-11	VTGNVistagen Therapeutics, Inc.M Exercise/Conversion	VP, CFO	MExercise/Conversion	+18.8K sh	$1.00	+$18.8K	94,571
2021-12-31	VTGNVistagen Therapeutics, Inc.A Award	VP, CFO	AAward	+3,575 sh	$1.66	+$5,925.563	75,821
2021-09-07	VTGNVistagen Therapeutics, Inc.S Sale	VP, CFO	SSale	−30K sh	$3.13	−$93.8K	72,786
2021-06-30	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	VP, CFO	MExercise/Conversion	−9,824 sh	—	—	140,176
2021-06-30	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	VP, CFO	DDisposition to Issuer	−36.7K sh	—	—	113,293
2021-06-30	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	VP, CFO	MExercise/Conversion	−78.9K sh	—	—	34,375
2021-06-30	VTGNVistagen Therapeutics, Inc.A Award	VP, CFO	AAward	+3,044 sh	$1.95	+$5,925.146	13,044
2021-06-30	VTGNVistagen Therapeutics, Inc.M Exercise/Conversion	VP, CFO	MExercise/Conversion	+1,000 sh	$1.50	+$1,500	14,044
2021-06-30	VTGNVistagen Therapeutics, Inc.M Exercise/Conversion	VP, CFO	MExercise/Conversion	+78.9K sh	$1.00	+$78.9K	92,962
2021-06-30	VTGNVistagen Therapeutics, Inc.M Exercise/Conversion	VP, CFO	MExercise/Conversion	+9,824 sh	$0.40	+$3,909.952	102,786
2021-06-30	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	VP, CFO	MExercise/Conversion	−1,000 sh	—	—	0
2020-12-31	VTGNVistagen Therapeutics, Inc.A Award	VP, CFO	AAward	+5,000 sh	$0.45	+$2,260.5	10,000
2020-12-30	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	VP, CFO	AAward	+150K sh	—	—	150,000
2020-06-30	VTGNVistagen Therapeutics, Inc.A Award	VP, CFO	AAward	+5,000 sh	$0.45	+$2,240	5,000
2020-04-23	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	VP, CFO	AAward	+150K sh	—	—	150,000
2019-10-21	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	VP, CFO	AAward	+150K sh	—	—	150,000
2019-05-23	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	VP, CFO	AAward	+150K sh	—	—	150,000
2018-08-29	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	VP, CFO	DDisposition to Issuer	−75K sh	—	—	0
2018-08-29	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	VP, CFO	DDisposition to Issuer	−678 sh	—	—	0
2018-08-29	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	VP, CFO	AAward	+678 sh	—	—	678
2018-08-29	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	VP, CFO	DDisposition to Issuer	−4,323 sh	—	—	0
2018-08-29	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	VP, CFO	AAward	+4,323 sh	—	—	4,323
2018-08-29	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	VP, CFO	DDisposition to Issuer	−1,000 sh	—	—	0
2018-08-29	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	VP, CFO	AAward	+1,000 sh	—	—	1,000
2018-08-29	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	VP, CFO	AAward	+75K sh	—	—	75,000
2018-08-29	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	VP, CFO	DDisposition to Issuer	−50K sh	—	—	0
2018-08-29	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	VP, CFO	AAward	+50K sh	—	—	50,000
2018-08-29	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	VP, CFO	DDisposition to Issuer	−100K sh	—	—	0
2018-08-29	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	VP, CFO	AAward	+100K sh	—	—	100,000
2018-08-05	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	VP, CFO	AAward	+100K sh	—	—	100,000
2018-02-02	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	VP, CFO	AAward	+200K sh	—	—	200,000
2017-09-19	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	VP, CFO	AAward	+100K sh	—	—	100,000
2017-04-26	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	VP, CFO	AAward	+100K sh	—	—	100,000
2016-11-09	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	VP, CFO	AAward	+50K sh	—	—	50,000
2016-06-19	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	VP, CFO	AAward	+75K sh	—	—	75,000
2015-11-11	VTGNVistagen Therapeutics, Inc. · Warrant for Common StockA Award	VP, CFO	AAward	+100K sh	—	—	100,000
2015-11-11	VTGNVistagen Therapeutics, Inc. · Warrant for Common StockD Disposition to Issuer	VP, CFO	DDisposition to Issuer	−10K sh	—	—	0
2015-11-11	VTGNVistagen Therapeutics, Inc. · Warrant for Common StockA Award	VP, CFO	AAward	+10K sh	—	—	10,000
2015-11-11	VTGNVistagen Therapeutics, Inc. · Warrant for Common StockD Disposition to Issuer	VP, CFO	DDisposition to Issuer	−5,000 sh	—	—	0
2015-11-11	VTGNVistagen Therapeutics, Inc. · Warrant for Common StockA Award	VP, CFO	AAward	+5,000 sh	—	—	5,000
2015-11-11	VTGNVistagen Therapeutics, Inc. · Warrant for Common StockD Disposition to Issuer	VP, CFO	DDisposition to Issuer	−50K sh	—	—	0
2015-11-11	VTGNVistagen Therapeutics, Inc. · Warrant for Common StockA Award	VP, CFO	AAward	+50K sh	—	—	50,000
2015-11-11	VTGNVistagen Therapeutics, Inc. · Warrant for Common StockD Disposition to Issuer	VP, CFO	DDisposition to Issuer	−100K sh	—	—	0
2015-09-02	VTGNVistagen Therapeutics, Inc. · Warrant for Common StockA Award	VP, CFO	AAward	+100K sh	—	—	100,000
2015-01-11	VTGNVistagen Therapeutics, Inc. · Warrant for Common StockA Award	VP, CFO	AAward	+50K sh	—	—	50,000

Recent filings

Accepted (ET)
Jul 54
DOTSON JERROLD DUANE0001415889-23-010719
SEC(opens sec.gov)
Jan 34
DOTSON JERROLD DUANE0001415889-23-000043
SEC(opens sec.gov)
Jul 154
DOTSON JERROLD DUANE0001415889-22-007686
SEC(opens sec.gov)
Mar 34
DOTSON JERROLD DUANE0001415889-22-002300
SEC(opens sec.gov)
Jan 124
DOTSON JERROLD DUANE0001415889-22-000507
SEC(opens sec.gov)
Jan 34
DOTSON JERROLD DUANE0001415889-22-000041
SEC(opens sec.gov)
Sep 84
DOTSON JERROLD DUANE0001415889-21-004287
SEC(opens sec.gov)
Jul 24
DOTSON JERROLD DUANE0001415889-21-003391
SEC(opens sec.gov)
Jan 44
DOTSON JERROLD DUANE0001415889-21-000018
SEC(opens sec.gov)
Jul 14
DOTSON JERROLD DUANE0001415889-20-001765
SEC(opens sec.gov)
Apr 274
DOTSON JERROLD DUANE0001415889-20-001067
SEC(opens sec.gov)

Companies

Address

C/O VISTAGEN THERAPEUTICS, INC. 384 OYSTER POINT BLVD. SUITE 8

SOUTH SAN FRANCISCO, CA, 94080